Lisata Therapeutics, Inc. (LSTA)
NASDAQ·Healthcare·Biotechnology
$1.05
+2.45%
Mkt Cap $15.39M
Analyst Ratings
Buy
0
Hold
1
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$1.05
+2.45%
Mkt Cap $15.39M
Buy
0
Hold
1
Sell
0
Price Target (— analysts)
—
Range — – —